Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NVAX | Common Stock | Sale | -$656K | -8.95K | -11.91% | $73.29* | 66.1K | Mar 31, 2022 | Direct | F1 |
transaction | NVAX | Common Stock | Sale | -$242K | -3.26K | -4.92% | $74.25* | 62.9K | Mar 31, 2022 | Direct | F2 |
transaction | NVAX | Common Stock | Sale | -$22.5K | -300 | -0.48% | $75.10* | 62.6K | Mar 31, 2022 | Direct | F3 |
holding | NVAX | Common Stock | 1.5K | Mar 31, 2022 | By spouse | F4 |
Id | Content |
---|---|
F1 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.98 to $73.91, inclusive. The reporting person undertakes to provide to Novavax, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
F2 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.01 to $74.98, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
F3 | The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.01 to $75.25, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. |
F4 | The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |